Every line on the tray is a patient-safety decision

A distributor is not moving boxes. Each product on the cataract tray touches the inside of a human eye, and a lapse in any of them shows up as a complication weeks later^[3]. That is why sourcing has to start from clinical quality and work back to price — never the other way round.

The good news: the list is short and well understood. Master the quality questions for six items and you can build a supply line that surgeons trust and programmes can afford. The rest of this playbook is that checklist.

What to demand from a supplier

Think in landed cost, not factory price

The cheapest quote rarely wins once you count everything it drags along. Landed cost is where sourcing decisions are actually made.

Illustrative. A slightly higher unit price with long shelf life, reliable supply and strong QC frequently wins on total landed cost.

High-volume surgery needs high-reliability supply

Sutureless small-incision techniques let a single surgeon restore sight to dozens of patients a day at outcomes comparable to phacoemulsification^[4][5]. That throughput only holds if the supply behind it is dependable — every camp day, every case. A distributor who guarantees consistent stock, long dating and registrable quality becomes part of the clinical result, not just its vendor.

Across Africa, Southeast Asia, Latin America and the Pacific islands, that reliability is the difference between a programme that grows and one that stalls waiting for the next shipment.

The chemistry a buyer must understand

You cannot judge an OVD you do not understand. Viscoelastics split into two families, and the best surgeons use both — sometimes in the same eye (the 'soft-shell' technique).

Cohesive OVDs are high-molecular-weight sodium hyaluronate (typically ~2–4 million Daltons, high zero-shear viscosity). They create and hold space beautifully — ideal for maintaining the anterior chamber and deepening it for capsulorhexis and IOL implantation — and they come out of the eye cleanly in one mass at the end. Dispersive OVDs (lower-molecular-weight hyaluronate or HPMC / hydroxypropyl methylcellulose) coat and cling to the corneal endothelium, forming a protective film that resists aspiration during turbulent steps like nucleus removal. HPMC's other virtue is economic: it is dramatically cheaper to produce, which is why it dominates high-volume surgery across the Global South.

So when a supplier offers 'a viscoelastic', the intelligent buyer asks: which chemistry, what molecular weight, what zero-shear and high-shear viscosity, and what is the batch-to-batch variance? A hyaluronate that swings in molecular weight between lots behaves differently in the surgeon's hands from one case to the next — and unpredictability in the anterior chamber is exactly what you are paying to avoid.

Score suppliers, don't just haggle

Replace gut feel with a weighted scorecard. The exact weights are yours to set, but a defensible starting point for a cataract programme looks like this:

Notice that unit price sits inside a 15% bucket, not at the top. A supplier who wins on the 30% and 20% lines but is 10% dearer per unit is almost always the better decision — because the cost of a single endophthalmitis case, a batch recall, or a mid-camp stockout dwarfs any per-unit saving^[3].

Red flags to walk away from

No certificate of analysis per batch. Reluctance to share technical documentation for registration. Vague or shifting shelf-life claims. Prices that are implausibly low for the stated quality (ask what was removed to get there). A single point of failure in the supply chain with no buffer. Any of these turns a bargain into a liability the moment it reaches a patient's eye.

References & peer-reviewed sources

The solutions behind the surgery

A single, registrable, quality-controlled source for the whole cataract tray — viscoelastics, capsule stain, intracameral antibiotic, and PMMA & foldable IOLs — priced for high-volume, cost-sensitive programmes.

Explore the full range on the Agaaz product portfolio.